Developer docs
API playgroundTry for free, no card

Search company profiles

MSD Animal Health

Full company profile

uuid003vqyo

Namestring
MSD Animal Health
Legal namestring
Intervet Ireland Ltd. t/a MSD Animal Health Ireland Ltd.
Company typeenum
Private
Founded yearint
1940
Descriptiontext

MSD Animal Health is the animal health subsidiary of Merck & Co., Inc. (NYSE: MRK), operating globally as a research-driven developer, manufacturer, and marketer of veterinary pharmaceuticals and biological products. Its portfolio spans vaccines, parasiticides, and anti-infectives organized across nine species categories including cattle, sheep, horses, dogs, cats, rabbits, pigs, poultry, and fish, with branded franchises such as Bravecto, Nobivac, Bovilis, NOBIVAC NXT Rabies, and Sense Hub. The company's technology layer includes the Sense Hub AI-based herd monitoring platform, which monitors 190,000 dairy cattle across 900 Brazilian farms and is positioned to grow from 10% to 25% of revenue by 2030, alongside proprietary vaccine platforms using RNA-particle, virus-like particle, and vitamin E-adjuvant technologies.

MSD Animal Health generates revenue primarily through one-time sales of pharmaceuticals and biologics distributed through veterinary practices for companion animals and through direct sales teams for livestock producers. A growing subscription-style revenue stream is emerging from Sense Hub AI monitoring, supported by proprietary data from monitored herds. The company sells through an ecosystem of practice-embedded tools including MSD Animal Health Academy (CVE-accredited CPD), VetHub, VetPerform, VetConsult, Healthier Pets Reminder Service, Chameleon digital design, and the Toxovax E-Shop, which deepen integration with veterinary practice workflows. The Irish operating entity, Intervet Ireland Ltd. t/a MSD Animal Health Ireland Ltd., is headquartered in Leopardstown, Dublin. The company recently acquired Elanco's aqua business (July 2024) to enter aquaculture and divested its Aprilia, Italy manufacturing site to Prange Pharma (April 2026) under a long-term supply agreement, reflecting active portfolio rebalancing toward higher-value biologics and technology platforms.

Short descriptiontext

MSD Animal Health is the animal health subsidiary of Merck & Co., developing and marketing veterinary vaccines, parasiticides, and AI-based herd monitoring technology across nine species for veterinary practices and livestock producers globally.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersDublin, Ireland
HQ citystring
Dublin
HQ countrystring
Ireland
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
veterinary pharmaceuticals, animal vaccines, parasite control products, veterinary biologics, herd monitoring technology
Industry3 codes
1Livestock & Production Animal Therapeutics (Rx)
CodeHLAMAEABPrimaryYes
2Multi-site/Corporate Group Operations Platforms (Franchise/MSO Tools, Standardization)
CodeHLAMAGAMPrimaryNo
3Veterinary Vaccines (Biologics)
CodeHLAMAEALPrimaryNo
NAICS code2 codes
  • Veterinary Services541940
  • Veterinary Services54194
SIC code1 code
  • Biological Products, (No Disgnostic Substances)2836
Product category
Veterinary Pharmaceuticals
No data
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model3 records
1Veterinary Pharmaceuticals and Biologics
TypeOne Time License
Description

Core revenue from pharmaceutical and biological products including vaccines, parasiticides, anti-infectives, and other veterinary medicines for companion animals and livestock.

valorinternational.globo.com
2Animal Health Technology Solutions
TypeSubscription Recurring
Description

Revenue from technology platforms including Sense Hub herd monitoring systems, contributing to the company's expansion beyond traditional pharmaceuticals. Expected to grow from 10% to 25% of revenue by 2030.

valorinternational.globo.com
3Aquaculture Business
TypeOne Time License
Description

Revenue from aqua business acquired from Elanco in July 2024, expanding MSD Animal Health's presence in fish health products.

futuremarketinsights.com
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Operations, Marketing or Sales, Supply Chain, Personnel
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 7 records shown
1NOBIVAC NXT Rabies
Description

Rabies vaccine portfolio using advanced RNA-particle technology launched in June 2024

openpr.com
+6 more records
Core offering1 text field

MSD Animal Health develops, manufactures, and markets a comprehensive portfolio of veterinary pharmaceuticals, biological products (vaccines), parasiticides, and anti-infectives for companion animals and livestock. The company also offers proprietary AI-powered technology platforms such as Sense Hub for dairy cattle herd monitoring and identification, alongside digital services supporting veterinary practice operations.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 190,000 animals monitored across 900 farms using Sense Hub technology in Brazil
+3 more records
Product overview1 text field

MSD Animal Health operates as a comprehensive animal health company offering a unified portfolio of veterinary pharmaceutical and biological products across multiple species (cattle, sheep, horses, dogs, cats, rabbits, pigs, poultry, fish). The portfolio includes vaccines (NOBIVAC NXT Rabies, Nobivac Respira Bb, foot-and-mouth disease vaccines), parasite control products (Bravecto), and herd monitoring technology (Sense Hub). Supporting infrastructure includes educational platforms (MSD Animal Health Academy), practice management tools (VetHub, VetPerform, VetConsult), digital services (Chameleon, Healthier Pets Reminder Service), and ecommerce (Toxovax E-Shop). The company serves both farm animal (cattle, sheep, pigs, poultry, fish) and companion animal (dogs, cats, horses, rabbits) segments through its species-organized product structure.

Product and service9 records
1Sense Hub
CategoryAnimal health technology / Herd monitoring
Description

AI-based herd monitoring and identification technology that monitors dairy cattle vital signs and behavior for early disease detection. Sold to commercial cattle producers, with 190,000 animals monitored across 900 farms in Brazil.

2NOBIVAC NXT Rabies portfolio
CategoryVeterinary vaccine
Description

Advanced rabies vaccine portfolio for cats and dogs using RNA-particle technology, formulated without adjuvants or preservatives to stimulate comprehensive immune responses. Sold through veterinary practices.

3Nobivac Respira Bb
CategoryVeterinary vaccine
Description

Novel injectable Bordetella bronchiseptica vaccine for dogs using a vitamin E-based oil-in-water adjuvant with purified fimbrial antigen. Provides an injectable alternative to existing intranasal or oral Bordetella vaccines. Sold through veterinary practices.

4Foot-and-Mouth Disease Vaccines
CategoryVeterinary vaccine
Description

Vaccines for foot-and-mouth disease in livestock, including thermostable, recombinant, and DIVA-compatible variants. MSD Animal Health is one of the key players in the global FMD vaccines market, serving livestock farmers.

5MSD Animal Health Academy
CategoryProfessional education platform
Description

Online e-learning platform containing courses and webinars for veterinary professionals, many CVE accredited. Access restricted to veterinary practitioners and veterinary nurses with a registered account.

6Chameleon Digital Design Service
CategoryDigital practice service
Description

Digital design and printing service providing personalized communications for veterinary practices including vaccination reminders (SMS, email, or postcard), vaccination certificates, and other client engagement materials.

7Healthier Pets Reminder Service
CategoryDigital practice service
Description

Web-based system allowing veterinary practices to set up text and email parasite treatment reminders for pet owner clients.

8Bovilis
CategoryLivestock health product line
Description

Cattle and sheep health product line serving cattle and sheep farmers to improve health and fertility, including vaccines and reproductive management products.

9Bravecto
Scale indicator20 records

Each record includes

Type, Value, Description, Source

Partnership5 partners
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2024-07-01
Description

MSD Animal Health acquired Elanco's aqua business in July 2024, expanding its presence in the aquaculture health market. This acquisition strengthened MSD Animal Health's portfolio in fish health products and expanded its market coverage in the aquaculture segment.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

MSD Animal Health is collaborating with researchers at Diamond Light Source and other institutions on a novel virus-like particle vaccine against foot-and-mouth disease. The vaccine is currently undergoing regulatory approvals. This partnership enables access to advanced research capabilities for vaccine development.

Strategic tierMinorTypeOthers
Description

Prange Pharma completed acquisition of the MSD Animal Health manufacturing site in Aprilia, Italy, rebranded as Aprilia Animal Health. The transaction includes a long-term supply partnership to ensure product continuity and expand Prange Pharma's capabilities in animal health manufacturing.

Strategic tierMinorTypeOthers
Description

Both companies identified as key industry players expanding capacity and compliance systems in the South Asia pet care market. While not formal partners, both compete in the same regional markets.

Strategic tierMinorTypeOthers
Description

Identified as key industry peer in South Asia pet care market alongside MSD Animal Health. Both companies expanding capacity in the rapidly growing regional market.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Animal health pharmaceutical company with companion animal and livestock products. Smaller-scale direct peer with overlapping parasiticide, anti-infective, and specialty therapeutic franchises.

TypeDirect peer
Description

Animal health and nutrition company focused on livestock (cattle, poultry, swine). Comparable in production-animal vaccines, medicated feed additives, and nutritional specialties.

TypeBroad incumbent
Description

Dominant veterinary diagnostics company whose in-clinic analyzers and tests complement MSD's therapeutic products. Competes for share of veterinary practice wallet and increasingly in animal-health data and monitoring.

TypeDirect peer
Description

Major animal health division of Boehringer Ingelheim with broad vaccines, parasiticides, and therapeutics portfolio. Direct competitor across companion animal vaccines (e.g., rabies) and livestock biologics.

TypeDirect peer
Description

Independent global animal health company with a portfolio spanning companion animal vaccines, parasiticides, dermatology, and livestock products. Comparable in breadth and species coverage to MSD Animal Health.

TypeBroad incumbent
Description

Operates veterinary services, diagnostics (Antech), and pet nutrition. While a competitor in the broader pet health ecosystem (especially South Asia), it overlaps more in services and nutrition than in pharma/biologics, making it a broad incumbent peer.

TypeDirect peer
Description

Global animal health company focused on vaccines, pharmaceuticals, and equipment for livestock and companion animals. Direct competitor, particularly strong in poultry and swine vaccines.

TypeDirect peer
Description

Specialty veterinary pharmaceuticals company with strong positions in companion animal endocrinology, dermatology, and equine. Comparable in companion animal focus and specialty pharma model.

TypeDirect peer
Description

The largest pure-play animal health company globally, with a comparable portfolio of vaccines, parasiticides, anti-infectives, and diagnostics across companion and livestock species. Most direct head-to-head competitor to MSD Animal Health in vaccines and parasiticides worldwide.

TypeDirect peer
Description

Direct competitor in livestock and companion animal health, recently divested its aqua business to MSD Animal Health. Competes head-to-head in vaccines, parasiticides, and nutritional health products.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment11 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature10 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment1 record

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

MSD Animal Health

Veterinary Pharmaceuticalsmsd-animal-health.ie

MSD Animal Health is the animal health subsidiary of Merck & Co., developing and marketing veterinary vaccines, parasiticides, and AI-based herd monitoring technology across nine species for veterinary practices and livestock producers globally.

What MSD Animal Health does

MSD Animal Health is the animal health subsidiary of Merck & Co., Inc. (NYSE: MRK), operating globally as a research-driven developer, manufacturer, and marketer of veterinary pharmaceuticals and biological products. Its portfolio spans vaccines, parasiticides, and anti-infectives organized across nine species categories including cattle, sheep, horses, dogs, cats, rabbits, pigs, poultry, and fish, with branded franchises such as Bravecto, Nobivac, Bovilis, NOBIVAC NXT Rabies, and Sense Hub. The company's technology layer includes the Sense Hub AI-based herd monitoring platform, which monitors 190,000 dairy cattle across 900 Brazilian farms and is positioned to grow from 10% to 25% of revenue by 2030, alongside proprietary vaccine platforms using RNA-particle, virus-like particle, and vitamin E-adjuvant technologies.

MSD Animal Health generates revenue primarily through one-time sales of pharmaceuticals and biologics distributed through veterinary practices for companion animals and through direct sales teams for livestock producers. A growing subscription-style revenue stream is emerging from Sense Hub AI monitoring, supported by proprietary data from monitored herds. The company sells through an ecosystem of practice-embedded tools including MSD Animal Health Academy (CVE-accredited CPD), VetHub, VetPerform, VetConsult, Healthier Pets Reminder Service, Chameleon digital design, and the Toxovax E-Shop, which deepen integration with veterinary practice workflows. The Irish operating entity, Intervet Ireland Ltd. t/a MSD Animal Health Ireland Ltd., is headquartered in Leopardstown, Dublin. The company recently acquired Elanco's aqua business (July 2024) to enter aquaculture and divested its Aprilia, Italy manufacturing site to Prange Pharma (April 2026) under a long-term supply agreement, reflecting active portfolio rebalancing toward higher-value biologics and technology platforms.

MSD Animal Health firmographics

Firmographics
Name
MSD Animal Health
Legal name
Intervet Ireland Ltd. t/a MSD Animal Health Ireland Ltd.
Website
https://msd-animal-health.ie
Company type
Private
Founded year
1940
Operating status
Operating
Headcount range
11–50 employees
Short description
MSD Animal Health is the animal health subsidiary of Merck & Co., developing and marketing veterinary vaccines, parasiticides, and AI-based herd monitoring technology across nine species for veterinary practices and livestock producers globally.
Ownership category
akta.pro rank

MSD Animal Health industry classification

Industry
Product category
Veterinary Pharmaceuticals
NAICS
Veterinary Services (541940), Veterinary Services (54194)
SIC
Biological Products, (No Disgnostic Substances) (2836)
akta.pro primary industry
Livestock & Production Animal Therapeutics (Rx) (HLAMAEAB)
akta.pro secondary industries
Multi-site/Corporate Group Operations Platforms (Franchise/MSO Tools, Standardization) (HLAMAGAM), Veterinary Vaccines (Biologics) (HLAMAEAL)

Keywords

  • Veterinary pharmaceuticals
  • Animal vaccines
  • Parasite control products
  • Veterinary biologics
  • Herd monitoring technology

Where MSD Animal Health is headquartered

Location

Headquarters

HQ city
Dublin
HQ country
Ireland
HQ region
Europe

Offices1 record

Markets served

MSD Animal Health business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Operations, Marketing or Sales, Supply Chain, Personnel

Revenue model

  1. Veterinary Pharmaceuticals and Biologics: Core revenue from pharmaceutical and biological products including vaccines, parasiticides, anti-infectives, and other veterinary medicines for companion animals and livestock.
  2. Animal Health Technology Solutions: Revenue from technology platforms including Sense Hub herd monitoring systems, contributing to the company's expansion beyond traditional pharmaceuticals. Expected to grow from 10% to 25% of revenue by 2030.
  3. Aquaculture Business: Revenue from aqua business acquired from Elanco in July 2024, expanding MSD Animal Health's presence in fish health products.

Go-to-market motion3 records

Distribution channels4 records

Marketing channels8 records

MSD Animal Health product offering

Product offering

Core offering

MSD Animal Health develops, manufactures, and markets a comprehensive portfolio of veterinary pharmaceuticals, biological products (vaccines), parasiticides, and anti-infectives for companion animals and livestock. The company also offers proprietary AI-powered technology platforms such as Sense Hub for dairy cattle herd monitoring and identification, alongside digital services supporting veterinary practice operations.

Product overview

MSD Animal Health operates as a comprehensive animal health company offering a unified portfolio of veterinary pharmaceutical and biological products across multiple species (cattle, sheep, horses, dogs, cats, rabbits, pigs, poultry, fish). The portfolio includes vaccines (NOBIVAC NXT Rabies, Nobivac Respira Bb, foot-and-mouth disease vaccines), parasite control products (Bravecto), and herd monitoring technology (Sense Hub). Supporting infrastructure includes educational platforms (MSD Animal Health Academy), practice management tools (VetHub, VetPerform, VetConsult), digital services (Chameleon, Healthier Pets Reminder Service), and ecommerce (Toxovax E-Shop). The company serves both farm animal (cattle, sheep, pigs, poultry, fish) and companion animal (dogs, cats, horses, rabbits) segments through its species-organized product structure.

Differentiator

Problem solved

Functional benefit

Brands

  • NOBIVAC NXT Rabies: Rabies vaccine portfolio using advanced RNA-particle technology launched in June 2024
  • Nobivac Respira Bb
  • Sense Hub
  • Chameleon
  • VetHub
  • MSD Animal Health Academy
  • Healthier Pets Reminder

Products and services

  • Sense Hub AI-based herd monitoring and identification technology that monitors dairy cattle vital signs and behavior for early disease detection. Sold to commercial cattle producers, with 190,000 animals monitored across 900 farms in Brazil.
  • NOBIVAC NXT Rabies portfolio Advanced rabies vaccine portfolio for cats and dogs using RNA-particle technology, formulated without adjuvants or preservatives to stimulate comprehensive immune responses. Sold through veterinary practices.
  • Nobivac Respira Bb Novel injectable Bordetella bronchiseptica vaccine for dogs using a vitamin E-based oil-in-water adjuvant with purified fimbrial antigen. Provides an injectable alternative to existing intranasal or oral Bordetella vaccines. Sold through veterinary practices.
  • Foot-and-Mouth Disease Vaccines Vaccines for foot-and-mouth disease in livestock, including thermostable, recombinant, and DIVA-compatible variants. MSD Animal Health is one of the key players in the global FMD vaccines market, serving livestock farmers.
  • MSD Animal Health Academy Online e-learning platform containing courses and webinars for veterinary professionals, many CVE accredited. Access restricted to veterinary practitioners and veterinary nurses with a registered account.
  • Chameleon Digital Design Service Digital design and printing service providing personalized communications for veterinary practices including vaccination reminders (SMS, email, or postcard), vaccination certificates, and other client engagement materials.
  • Healthier Pets Reminder Service Web-based system allowing veterinary practices to set up text and email parasite treatment reminders for pet owner clients.
  • Bovilis Cattle and sheep health product line serving cattle and sheep farmers to improve health and fertility, including vaccines and reproductive management products.
  • Bravecto

Quantifiable outcome

  • 190,000 animals monitored across 900 farms using Sense Hub technology in Brazil
  • +3 more outcomes

Companies that use MSD Animal Health

Customer profile

Named customers3 records

Segments11 records

Ideal customer profiles3 records

MSD Animal Health technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature10 records

MSD Animal Health partnerships and signals

Strategic signal

Partnerships

Five partnerships are on record, tiered core and minor.

  • Elanco Animal HealthcoreTechnology or Integration · 1 July 2024MSD Animal Health acquired Elanco's aqua business in July 2024, expanding its presence in the aquaculture health market. This acquisition strengthened MSD Animal Health's portfolio in fish health products and expanded its market coverage in the aquaculture segment.
  • Diamond Light Source and Collaborating InstitutionscoreStrategic or Co-development PartnerMSD Animal Health is collaborating with researchers at Diamond Light Source and other institutions on a novel virus-like particle vaccine against foot-and-mouth disease. The vaccine is currently undergoing regulatory approvals. This partnership enables access to advanced research capabilities for vaccine development.
  • Prange PharmaminorOthersPrange Pharma completed acquisition of the MSD Animal Health manufacturing site in Aprilia, Italy, rebranded as Aprilia Animal Health. The transaction includes a long-term supply partnership to ensure product continuity and expand Prange Pharma's capabilities in animal health manufacturing.
  • Mars PetcareminorOthersBoth companies identified as key industry players expanding capacity and compliance systems in the South Asia pet care market. While not formal partners, both compete in the same regional markets.
  • Nestlé PurinaminorOthersIdentified as key industry peer in South Asia pet care market alongside MSD Animal Health. Both companies expanding capacity in the rapidly growing regional market.

Scale indicators20 records

Recent moves7 records

Expansion highlights6 records

MSD Animal Health competitors and assessment

Company assessment

Direct peers

  • Vetoquinol: Animal health pharmaceutical company with companion animal and livestock products. Smaller-scale direct peer with overlapping parasiticide, anti-infective, and specialty therapeutic franchises.
  • Phibro Animal Health: Animal health and nutrition company focused on livestock (cattle, poultry, swine). Comparable in production-animal vaccines, medicated feed additives, and nutritional specialties.
  • Boehringer Ingelheim Animal Health: Major animal health division of Boehringer Ingelheim with broad vaccines, parasiticides, and therapeutics portfolio. Direct competitor across companion animal vaccines (e.g., rabies) and livestock biologics.
  • Virbac: Independent global animal health company with a portfolio spanning companion animal vaccines, parasiticides, dermatology, and livestock products. Comparable in breadth and species coverage to MSD Animal Health.
  • Ceva Santé Animale: Global animal health company focused on vaccines, pharmaceuticals, and equipment for livestock and companion animals. Direct competitor, particularly strong in poultry and swine vaccines.
  • Dechra Pharmaceuticals: Specialty veterinary pharmaceuticals company with strong positions in companion animal endocrinology, dermatology, and equine. Comparable in companion animal focus and specialty pharma model.
  • Zoetis: The largest pure-play animal health company globally, with a comparable portfolio of vaccines, parasiticides, anti-infectives, and diagnostics across companion and livestock species. Most direct head-to-head competitor to MSD Animal Health in vaccines and parasiticides worldwide.
  • Elanco Animal Health: Direct competitor in livestock and companion animal health, recently divested its aqua business to MSD Animal Health. Competes head-to-head in vaccines, parasiticides, and nutritional health products.

Broad incumbents

  • IDEXX Laboratories: Dominant veterinary diagnostics company whose in-clinic analyzers and tests complement MSD's therapeutic products. Competes for share of veterinary practice wallet and increasingly in animal-health data and monitoring.
  • Mars Petcare: Operates veterinary services, diagnostics (Antech), and pet nutrition. While a competitor in the broader pet health ecosystem (especially South Asia), it overlaps more in services and nutrition than in pharma/biologics, making it a broad incumbent peer.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

MSD Animal Health financial estimates

Financial estimate

Revenue estimate

Valuation estimate

MSD Animal Health leadership team

Management profile

Number of profiles

MSD Animal Health subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

MSD Animal Health funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

MSD Animal Health M&A and investment

M&A and investment

M&A

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MSD Animal Health

What does MSD Animal Health do?

MSD Animal Health develops, manufactures, and markets a comprehensive portfolio of veterinary pharmaceuticals, biological products (vaccines), parasiticides, and anti-infectives for companion animals and livestock. The company also offers proprietary AI-powered technology platforms such as Sense Hub for dairy cattle herd monitoring and identification, alongside digital services supporting veterinary practice operations.

Is MSD Animal Health a public or private company?

MSD Animal Health is a private company. It is classified as corporate owned and is currently operating.

When was MSD Animal Health founded?

MSD Animal Health was founded in 1940. It employs 11 to 50 people.

Where is MSD Animal Health based?

MSD Animal Health is headquartered in Dublin, Ireland, in the Europe region.

How does MSD Animal Health make money?

Three revenue lines are on record. Veterinary Pharmaceuticals and Biologics are the primary driver. The others are animal Health Technology Solutions and aquaculture Business.

Who are MSD Animal Health's main competitors?

Direct peers on record are Vetoquinol, Phibro Animal Health, Boehringer Ingelheim Animal Health, Virbac, Ceva Santé Animale, Dechra Pharmaceuticals, Zoetis and Elanco Animal Health. Broad incumbents are IDEXX Laboratories and Mars Petcare.

Does MSD Animal Health have an API?

No public API is recorded for MSD Animal Health.

What industry is MSD Animal Health in?

MSD Animal Health's product category is Veterinary Pharmaceuticals. Its primary akta.pro industry code is HLAMAEAB, Livestock & Production Animal Therapeutics (Rx), with a secondary code of HLAMAGAM, Multi-site/Corporate Group Operations Platforms (Franchise/MSO Tools, Standardization). Its NAICS code is 541940 and its SIC code is 2836.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Grand View ResearchVeterinary Contract Manufacturing Market Report, 2026-2033The global veterinary contract manufacturing market was valued at USD 4.0 billion in 2025 and is projected to grow to USD 7.7 billion by 2033, representing a compound annual growth rate of 8.6% over the forecast period. Europe held the largest regional market share at 31.1% in 2025, while the Asia Pacific region is anticipated to be the fastest-growing market going forward. Key growth drivers include increasing outsourcing by animal health companies, capacity expansion in multi-species manufacturing facilities, rising demand for biologics and vaccines, and favorable regulatory frameworks supporting contract manufacturing organizations.pegnMSD bets on technology to expand in animal healthMSD Animal Health, the animal health subsidiary of U.S.-based MSD, is strengthening its focus on technology solutions for Brazilian cattle producers, expecting AI-based herd monitoring and identification to grow from 10% to 25% of its revenue by 2030. The company's Sense Hub technology, which monitors dairy cattle vital signs and behavior for early disease detection, has expanded from 8,000 to 190,000 monitored animals across 900 farms since its Brazil launch seven years ago, targeting 230,000 by year-end. MSD posted global revenue of $16.4 billion in 2025, up 5%, with Brazil delivering R$2.1 billion in revenue and 10% growth, while holding dominant 50% and 70% market shares in animal-monitoring and cattle-identification segments respectively.GlobeNewswireFarm Animal Drugs Research Report 2026: $28.88 Bn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035FResearchAndMarkets.com published the Farm Animal Drugs Market Report 2026, projecting the market to grow from $20.66 billion in 2025 to $21.96 billion in 2026 at a 6.3% CAGR, reaching $28.88 billion by 2030 at a 7.1% CAGR. Growth drivers include increased global meat consumption, rising livestock disease prevalence, antimicrobial stewardship emphasis, and expansion of commercial farming. Notable recent activities include Norbrook Laboratories launching Tauramox (generic moxidectin) in March 2023 and MSD Animal Health acquiring Elanco's aqua business in July 2024, while tariffs have increased costs for imported active ingredients and finished products.MDPIA Novel Vitamin E Adjuvanted Injectable Bordetella bronchiseptica Vaccine Is Safe and Efficacious in DogsMSD Animal Health researchers developed and evaluated a novel injectable Bordetella bronchiseptica vaccine (Nobivac Respira Bb) using a vitamin E-based oil-in-water adjuvant with purified fimbrial antigen, conducting three complementary studies in Beagle puppies and pregnant dams. The vaccine demonstrated safety in 5–6-week-old puppies when administered concurrently with core canine vaccines (DHPPi and L4) without interference, an onset of immunity of two weeks post-vaccination, and significant reduction in both clinical signs and bacterial excretion following B. bronchiseptica challenge. Furthermore, the vaccine proved equally efficacious in puppies with maternally derived antibodies and was safe for use in pregnant bitches, offering a practical injectable alternative to existing intranasal or oral Bordetella vaccines.openPR.comCat Vaccine Market Overview, Key Trends, and Major Player AnalysisThe cat vaccine market is projected to reach $1.93 billion by 2030, growing at a compound annual growth rate of 8.9%, driven by advances in vaccine technology and increasing pet health awareness. In September 2024, Boehringer Ingelheim Group acquired Saiba Animal Health AG, a Switzerland-based company specializing in cat vaccines, to expand its portfolio in this sector. In June 2024, MSD Animal Health Inc. launched the NOBIVAC NXT Rabies portfolio, featuring vaccines formulated without adjuvants or preservatives that stimulate comprehensive immune responses.YouTubeCork farmers push forward with technologyAgriland Media Group is partnering with MSD Animal Health to explore the use of SenseHub Dairy Monitoring Technology among Cork farmers. This technology allows for 24-hour animal monitoring to detect illness early, reducing welfare issues and financial strain on farmers ahead of the breeding season.Market Research & Business IntelligencePet Care Industry Analysis in South AsiaFuture Market Insights published a comprehensive analysis estimating the South Asia pet care market at USD 8.3 billion in 2026, projecting growth to USD 23.5 billion by 2036 at an 11.0% CAGR, with Indonesia leading at 12.5% CAGR followed by Vietnam (11.8%), Philippines (11.0%), Thailand (10.5%), Malaysia (10.0%), and Singapore (8.5%). The report attributes growth to repeat purchase conversion, governance-led supply formalisation, and companion animal health investment, noting that pet food drives 62.0% of spend, dogs account for 52.0% of demand, and dry food leads formats at 55.0%, while key industry players including Mars Petcare, Nestlé Purina, Zoetis, MSD Animal Health, Boehringer Ingelheim, i-Tail, Virbac, and Hill's are expanding capacity and compliance systems to capture growth.Vet CandyVaccine against foot-and-mouth disease could deliver $1.3 billion a year in global livestock benefitsResearchers at Diamond Light Source and collaborating institutions developed a novel virus-like particle vaccine against foot-and-mouth disease, projected to deliver $1.3 billion in annual economic benefits and $11 billion in avoided losses over ten years at 20% market penetration. The vaccine offers significant advantages over traditional options, including greater heat stability, safer manufacturing without live virus handling, and simpler storage and transport requirements, making it better suited for endemic regions with unreliable cold-chain infrastructure. The vaccine is currently undergoing regulatory approvals with MSD Animal Health, and the technology platform is expected to inform vaccine strategies for other livestock and zoonotic diseases.Agriland.ieInformation evenings organised for Wagyu breeding and benefitsTwo information evenings are being held in Ireland this week for dairy farmers interested in breeding Wagyu beef cattle, organized by meat processor Kepak, Munster Bovine, and MSD Animal Health. The events will explain the benefits of the Warrendale Wagyu Ireland programme, which offers a guaranteed price of €400 per calf and a bonus of €1.50-1.70/kg above average quoted price for farmers who finish the cattle themselves. Separately, Kepak was named winner in the large business category at the 2025 Sustainable Energy Authority of Ireland (SEAI) Energy Awards for achievements in energy management and decarbonisation.openPR.comGermany Veterinary Healthcare Market Size, Trends 2032 By Key Players- Boehringer Ingelheim Vetmedica GmbH, MSD Animal Health, Zoetis Deutschland GmbH, IDEXX Laboratories GmbHThe Germany veterinary healthcare market was valued at USD 2.19 billion in 2023 and is projected to reach USD 3.26 billion by 2031, a CAGR of 5.1%. Growth is driven by rising pet ownership, digital solutions, and regulatory support, with key players including Boehringer Ingelheim, MSD, Zoetis, and IDEXX.